Atrial Fibrillation: JACC Council Perspectives

Area of Science:

• Cardiology and Electrophysiology
• Medical Device Technology

Background:

• Atrial fibrillation (AF) is a growing public health concern with complex pathophysiology.
• Established risk models exist for stroke and bleeding, guiding prophylaxis decisions.
• Current therapeutic cornerstones include rate/rhythm control and stroke prevention.

Purpose of the Study:

• To provide a contemporary review of atrial fibrillation (AF).
• To cover prevalence, pathophysiology, risk prediction, and evolving treatment strategies.
• To discuss new insights and emerging concepts for optimizing AF management.

Main Methods:

• Review of current literature on AF pathophysiology, risk stratification, and treatment.
• Analysis of established and emerging diagnostic tools for assessing AF burden.
• Evaluation of therapeutic strategies, including pharmacologic agents and ablation techniques.

Main Results:

• AF ablation, particularly pulmonary vein isolation, is a primary therapeutic strategy.
• Advancements in ablation safety, efficacy, and techniques for nonparoxysmal AF are progressing.
• New technologies and approaches for stroke prophylaxis are under exploration.

Conclusions:

• Optimizing AF treatment requires integrating risk prediction, evolving prophylaxis, and advanced ablation.
• Continued research into novel ablation techniques and technologies is crucial.
• A comprehensive approach is necessary to improve outcomes for patients with atrial fibrillation.